Dr. John Hawboldt


Dr. John Hawboldt
Associate Professor
Cross appointed, Faculty of Medicine (Respirology); Eastern Health (Department of Pharmacy)

John Hawboldt

John graduated from the University of Saskatchewan in 1992, completed a Hospital Pharmacy Residency at Alberta Children’s Hospital the following year and completed a Doctor of Pharmacy from the University of Washington in 2004.

In between all of that, he has worked in a variety of patient care areas in both hospital and community settings. John joined the Faculty at the School of Pharmacy at MUN in 2004.

He is currently also cross-appointed to the Department of Pharmacy and Respirology at Eastern Health and MUN. He has an interest in antimicrobial stewardship and serves on both the Eastern Health and the Provincial Committees. Primary areas of interest in teaching and research include infectious diseases and respirology. His current clinical practice site is with the Cystic Fibrosis Program of Eastern Health (both adult and pediatric).

Research Areas of Interest:

  • Scholarship of Teaching and Learning (curriculum development/assessment)
  • Health as it relates to improved care
  • Improved patient outcomes
  • Antimicrobial stewardship

Teaching Areas of Interest:

  • Infectious disease
  • Gastrointestinal and respirology pharmacotherapy


Current Projects:

  • COPD and adherence to medications
  • Curriculum Assessment and Outcome Achievement

Recent Publications:

  • Bader M, Hawboldt J, Main C, Mertz D, Loeb M, Farrell A & Joyce J. Review of High Dose Vancomycin in The Treatment of Clostridioides difficile infection. Infectious Diseases. Published On-line. 2020. DOI: 10.1080/23744235.2020.1800080
  • Alwashmi, M. F., Fitzpatrick, B., Davis, E., Gamble, J. M., Farrell, J., & Hawboldt, J. Perceptions of Patients Regarding a Mobile Health Intervention for the Management of Chronic Obstructive Pulmonary Disease: A mixed-Methods Study. JMIR Mhealth Uhealth. 2020;23;8(7):e17409.
  • Alwashmi, M. F., Fitzpatrick, B., Davis, E., Gamble, J. M., Farrell, J., & Hawboldt, J. Features of a Mobile Health Intervention to Manage Chronic Obstructive Pulmonary Disease: a Qualitative Study. Therapeutic advances in respiratory disease. Accepted for Publication 2020
  • Alwashmi, M. F., Fitzpatrick, B., Davis, E., Gamble, J. M., Farrell, J., & Hawboldt, J. Perceptions of Health Care Providers Regarding a Mobile Health Intervention to Manage Chronic Obstructive Pulmonary Disease: Qualitative Study. JMIR mHealth Uhealth 2019, 7(6), e13950
  • Alwashmi A, Hawboldt J, Davis E, Fetters M. The Iterative Convergent Design for Mobile Health Usability Testing: Mixed-Methods Approach. JMIR Mhealth Uhealth 2019;7(4):e11656.

Full Publications:

  • Bader M, Hawboldt J, Main C, Mertz D, Loeb M, Farrell A & Joyce J. Review of High Dose Vancomycin in The Treatment of Clostridioides difficile infection. Infectious Diseases. Published On-line. 2020. DOI: 10.1080/23744235.2020.1800080
  • Alwashmi, M. F., Fitzpatrick, B., Davis, E., Gamble, J. M., Farrell, J., & Hawboldt, J. Perceptions of Patients Regarding a Mobile Health Intervention for the Management of Chronic Obstructive Pulmonary Disease: A mixed-Methods Study. JMIR Mhealth Uhealth. 2020;23;8(7):e17409.
  • Alwashmi, M. F., Fitzpatrick, B., Davis, E., Gamble, J. M., Farrell, J., & Hawboldt, J. Features of a Mobile Health Intervention to Manage Chronic Obstructive Pulmonary Disease: a Qualitative Study. Therapeutic advances in respiratory disease. Accepted for Publication 2020
  • Alwashmi, M. F., Fitzpatrick, B., Davis, E., Gamble, J. M., Farrell, J., & Hawboldt, J. Perceptions of Health Care Providers Regarding a Mobile Health Intervention to Manage Chronic Obstructive Pulmonary Disease: Qualitative Study. JMIR mHealth Uhealth 2019, 7(6), e13950
  • Alwashmi A, Hawboldt J, Davis E, Fetters M. The Iterative Convergent Design for Mobile Health Usability Testing: Mixed-Methods Approach. JMIR Mhealth Uhealth 2019;7(4):e11656.
  • Fitzpatrick B, Lee T, Smith MJ, Hawboldt, J. Validation of a Cystic Fibrosis Medication Knowledge Questionnaire. Glob Pediatr Health. 2017; 4
  • Hawboldt J, Nash R, FitzPatrick B. How Two Small Pharmacy Schools’ Competency Standards Compare with an International Competency Framework and How: Well These Schools Prepare Students for International Placements. Pharmacy 2017;5(14):1.
  • E Davis, C Marra, JM Gamble, J Farrell, H Lockyer, J M FitzGerald, W Abu-Ashour, C Gillis and J Hawboldt.Effectiveness of a pharmacist-driven intervention in COPD (EPIC): A pragmatic cluster randomized controlled trial. Trials. 2016;17(1):502.
  • Alwashmi M., Hawboldt J., Davis E., Marra C. Gamble J., Abu Ashour W. The effect of smartphone interventions on patients with Chronic Obstructive Pulmonary Disease exacerbations: A systematic review and meta-analysis. JMIR Mhealth Uhealth. 2016 Sep 1;4(3).
  • Bader S, Yanqing Y, Abouchehade K, Haroon B, Bishop L, Hawboldt J. Community-Acquired Pneumonia in Patients With Diabetes Mellitus: Predictors of Complications and Length of Hospital Stay. The American Journal of the Medical Sciences. 2016;352(1):30-5.
  • Bader,M.S.; Yi,Y.; Abouchehade,K.; Haroon,B.; Bishop,L.D.; Hawboldt,J. Community-acquired pneumonia in elderly patients with diabetes mellitus: Outcomes and time to first dose of appropriate antibiotic therapy. Infectious Diseases in Clinical Practice. 2015;23:6(294-300).
  • Bader M, Yanqing Y, Babar H, Abouchehade K, Bishop L, Hawboldt J. Community-Acquired Pneumonia in Older and Younger Adults With Diabetes Mellitus(Abstract). Chest. 2015;148:130A
    Hawboldt J., FitzPatrick B., Lee T., Smith M. Validation of a medication knowledge questionnaire for cystic fibrosis (Abstract). Pediatric Pulmonology. 2015;50 (SUPPL):41 (452).
  • Bishop L, Young Y, Twells L, Dillon C, Hawboldt J. Patients’ and physicians’ satisfaction with a pharmacist managed anticoagulation program in a family medicine clinic. BMC Research Notes. 2015;8(1):233.
  • FitzPatrick B, Doyle D, Genge T, Hawboldt J. Alignment of learning objectives and assessments in Pharmacy Therapeutics Courses to foster higher level thinking. American Journal of Pharmaceutical Education. 2014;79(1):1-8.
  • Kelly DV, Bishop L, Young S, Hawboldt J, Phillips L, Keough TM. Pharmacist and physician views on collaborative practice: Findings from the community pharmaceutical care project. Can Pharm J (Ott). 2013;146(4):218-26.
  • Hawboldt J., Davis E., Mccarthy R. Quality of life and related factors in patients with cystic fibrosis in Newfoundland and Labrador (Abstract). Journal of Cystic Fibrosis 2013:12; SUPPL.1 (S128)
  • Housser E, Mathews M, Lemessurier J, Young S, Hawboldt J, West R. Responses by breast and prostate cancer patients to out-of-pocket costs in Newfoundland and Labrador. Curr Oncol. 2013 Jun;20(3):158-65
  • McCarthy R, Davis E, Hawboldt J. Real-World Challenges to the Practice of Evidence-Based Medicine. Canadian Journal of Hospital Pharmacy. 2012;65(6):466.
  • Young S, Bishop L, Twells L, Dillon C, Hawboldt J, O’Shea P. Comparison of Pharmacist Managed Anticoagulation with Usual Care in a Family Medicine Clinic. BMC Family Practice 2011;12(88):1-7
  • Bader M, Hawboldt J, Twells L. Risk Factors of Cellulitis Treatment Failure with Once-daily Intravenous Cefazolin plus Oral Probenecid. Southern Medical Journal 2011; 104(12):789-93.
  • Bader MS, Abouchehade KA, Yi Y, Haroon B, Bishop LD, Hawboldt J. Antibiotic administration longer than eight hours after triage and mortality of community-acquired pneumonia in patients with diabetes mellitus. Eur J Clin Microbiol Infect Dis. 2011;30(7):881-6. Epub 2011 Feb 1.
  • Bader MS, Hawboldt J, Haroon B, Trahey J. Disseminated intravascular coagulation and venous thromboembolism due to acute epstein-barr virus infection. Infect Dis in Clin Pract. 2011;19(4):284-285.
  • Bader M, Hawboldt J, Brooks A. Management of Complicated Urinary Tract Infections in the Era of Antimicrobial Resistance. Postgrad Med. 2010;122(6):1-15.
  • Bader MS, Hawboldt J. Antibiotic Prescribing and Antimicrobial Resistance. Postgrad Med. 2010;122(4):227-229.
  • Young SW, Hawboldt J, Pierce G. Use of Evidence-Based Therapy at Discharge for Patients with Acute Myocardial Infarction – A Retrospective Chart Audit. Canadian Journal of Hospital Pharmacy. 2010;63(3):207-211.
  • Cowan C, Bader M, Hawboldt J. Pulmonary Infection due to Mycobacterium malmoense in a Patient with Crohn’s Disease. Canadian Journal of Hospital Pharmacy. 2009;62(6):493–496.
  • Hawboldt J. Irritable Bowel Syndrome. US Pharmacist. 2009;34(12):Epub
  • Harder C, Hawboldt J. A Survey of Canadian Pharmacists' Response to Recent Warnings Concerning the Potential for Interaction Between Ceftriaxone and Intravenous Calcium-Containing Solutions. Canadian Journal of Hospital Pharmacy. 2009;62(6):483–489.
  • Bader M, Hawboldt J. TRUST Surveillance: Antimicrobial Resistance Among Bacterial Respiratory Tract Pathogens. Postgraduate Medicine. 2009;121(2):208-07.
  • Bader M, Hawboldt J. Vaccination for Older Adults. Clinical Geriatrics. 2008;16(9):38-45.
  • Hawboldt J. Adverse Effects Associated with NSAIDs. US Pharmacist (Health Systems Edition). 2008;33(12):HS-5-HS-13.
  • Hawboldt J. Community-Acquired Pneumonia. US Pharmacist. 2007;32(10):44-50.
  • Hawboldt J, Bader M. Intramuscular Methotrexate Induced Aseptic Meningitis. Annals of Pharmacotherapy. 2007;41:1906-1911.
  • Hawboldt J, McGrath. Possible Metoprolol-Induced Hyperkalemia. Journal of Pharmacy Practice. 2006;19:320-325.
  • Hawboldt J. Addicted, helping patients deal with opioid dependence. Pharmacy Practice. 2006;22(8):26-32.
  • Hawboldt J. C.difficile-associated diarrhea: what can you do? Pharmacy Practice. 2005;21(5):27-34.

Contact: Dr. John Hawboldt

Email: hawboldt@mun.ca

Phone: (709) 864-2090

Contact

School of Pharmacy

230 Elizabeth Ave, St. John's, NL, CANADA, A1B 3X9

Postal Address: P.O. Box 4200, St. John's, NL, CANADA, A1C 5S7

Tel: (709) 864-8000